Dorsomorphin (Compound C): Unveiling AMPK and BMP/Smad Signal Modulation in Inflammation and Regenerative Biology

Introduction

Dorsomorphin (Compound C) has emerged as a cornerstone molecule for dissecting cellular energy regulation, autophagy, and differentiation pathways in modern biomedical research. While previous reviews have highlighted its dual role as an ATP-competitive AMPK inhibitor and BMP signaling inhibitor, this article delves deeper, uniquely focusing on its utility in immune modulation, metabolic disease models, and regenerative biology. By integrating mechanistic details, recent breakthroughs in immune inflammation, and advanced experimental applications, we provide a comprehensive perspective for researchers seeking to leverage Dorsomorphin for next-generation discovery.

Mechanism of Action of Dorsomorphin (Compound C)

AMPK Inhibition: ATP-Competitive and Highly Selective

Dorsomorphin, also known as Compound C, is a cell-permeable, reversible, ATP-competitive inhibitor of AMP-activated protein kinase (AMPK) with a Ki of 109 nM. This high-affinity interaction underpins its selectivity for AMPK over other kinases such as protein kinase A, protein kinase C, and Janus kinase 3. Through this inhibition, Dorsomorphin blocks the phosphorylation of key AMPK substrates, most notably acetyl-CoA carboxylase (ACC), reducing its phosphorylation by up to 80% in cell-based assays. This leads to profound effects on lipid metabolism and autophagy regulation across diverse cell types.

BMP/Smad Signaling Pathway Inhibition

Beyond its role in energy sensing, Dorsomorphin is a potent inhibitor of the BMP/Smad signaling pathway. It disrupts BMP4-induced phosphorylation of Smad 1/5/8 with an IC₅₀ of 0.47 μM, thereby inhibiting downstream gene transcription involved in osteogenesis, iron regulation, and neural fate decisions. This dual-pathway inhibition has positioned Dorsomorphin as an indispensable probe for studying the crosstalk between metabolism, differentiation, and inflammation.

Advanced Insights: Dorsomorphin in Inflammation and Immune Modulation

The AMPK Signaling Pathway in Macrophage Polarization and Inflammation

A pivotal study recently published in Inflammation (Jiahui Lei et al., 2025) elucidated the regulatory role of AMPK in macrophage polarization and airway inflammation within obesity-related asthma models. Here, the downregulation of AMPK expression was associated with increased M1 macrophage polarization and exacerbated inflammation. Conversely, exogenous AMPK activation, which Dorsomorphin can experimentally antagonize, attenuated M1 polarization via the JAK2/STAT3 pathway and reduced pro-inflammatory cytokine production. These findings define the AMPK signaling pathway as a crucial target for understanding and manipulating immune cell function in chronic inflammatory diseases.

Experimental Applications: Dorsomorphin as a Tool for Immune Research

By leveraging Dorsomorphin's ability to inhibit AMPK activity in hepatocytes, HeLa cells, and immune cell models, researchers can dissect the consequences of AMPK suppression on macrophage phenotype, cytokine secretion, and systemic metabolic inflammation. This strategic use of Dorsomorphin enables:

• Dissection of the JAK2/STAT3 axis in macrophage function under metabolic stress
• Elucidation of mechanisms underlying insulin resistance and chronic airway inflammation
• Development of precise in vitro and in vivo models for metabolic-immune crosstalk

This application focus distinguishes our analysis from prior articles that emphasized autophagy and differentiation mechanisms (see advanced insights here), by highlighting Dorsomorphin's value in immune modulation and disease modeling.

Autophagy Regulation and Metabolic Pathway Dissection

Dorsomorphin's inhibition of AMPK-driven phosphorylation cascades, including ACC phosphorylation inhibition, significantly affects autophagic flux and cellular energy homeostasis. By suppressing AMPK, Dorsomorphin impedes autophagic proteolysis, providing an experimental avenue to study autophagy's role in disease progression, cancer cell survival, and therapy resistance. This is particularly valuable for researchers seeking to parse the interplay between metabolism and autophagy in complex disease contexts.

Modulation of Iron Metabolism: From Hepcidin to Systemic Iron Levels

Dorsomorphin also functions as a powerful modulator of iron metabolism by inhibiting BMP/Smad signaling, thereby reducing hepatic hepcidin gene transcription. This results in increased serum iron concentrations and altered systemic iron homeostasis. Animal studies have confirmed its efficacy in modulating hepcidin mRNA and iron levels, making it a unique tool for modeling iron overload disorders and studying the intersection of metabolic and hematologic pathways.

Neural Stem Cell Differentiation and Regenerative Medicine

Recent research has leveraged Dorsomorphin to promote self-renewal and neural induction in human embryonic stem cells. By inhibiting BMP signaling, Dorsomorphin fosters neural lineage commitment, providing a chemical means to steer stem cell fate and enhance the efficiency of neural differentiation protocols. This application has far-reaching implications for regenerative medicine, disease modeling, and the development of cell-based therapies for neurodegenerative conditions.

Comparative Analysis: Dorsomorphin Versus Alternative Pathway Modulators

While other AMPK inhibitors and BMP antagonists are available, Dorsomorphin's unique dual-action profile enables simultaneous interrogation of metabolic and differentiation pathways. Unlike more recently developed pathway-specific inhibitors, Dorsomorphin offers researchers the flexibility to model complex interdependent signaling events within a single system. This contrasts with scenario-driven guides such as this practical laboratory workflow article, which emphasizes reproducibility and troubleshooting, whereas our analysis foregrounds mechanistic exploration and translational insight across immune, metabolic, and stem cell biology.

Practical Considerations for Experimental Use

• Solubility: Dorsomorphin is insoluble in water and ethanol, but dissolves in DMSO at concentrations ≥8.49 mg/mL with gentle warming and sonication.
• Storage: Supplied as a solid and should be stored at -20°C. Solutions are not recommended for long-term storage and should be used promptly.
• Recommended Usage: Typical concentrations range from 4–40 μM in cell culture and 10 mg/kg (intraperitoneal) in animal models.
• Applications: Inhibition of AMPK activity in hepatocytes, BMP4-induced SMAD phosphorylation inhibition, neural induction, and dorsalization in zebrafish embryos.

For more details and to order, visit the Dorsomorphin (Compound C) product page (SKU: B3252) from APExBIO.

Expanding the Research Frontier: Dorsomorphin in Cancer and Disease Modeling

Emerging studies are leveraging Dorsomorphin in cancer research to interrogate the role of AMPK signaling in cell survival, proliferation, and autophagy. By manipulating metabolic checkpoints, Dorsomorphin enables modeling of metabolic vulnerabilities in tumor cells and assessment of therapeutic strategies targeting the AMPK axis. Furthermore, its dual-pathway modulation is increasingly valuable in constructing advanced models of metabolic, inflammatory, and differentiation-driven diseases, providing a more holistic understanding than pathway-specific inhibitors alone.

Content Hierarchy and Strategic Differentiation

Whereas previous articles have primarily focused on the translational or scenario-driven deployment of Dorsomorphin—such as the strategic framework for dual-pathway targeting outlined in this strategic dual-pathway piece—this article uniquely synthesizes recent findings on immune modulation, inflammation, and regenerative biology. By integrating the latest mechanistic insights from the reference paper on AMPK-mediated macrophage polarization and inflammation (Lei et al., 2025), our review widens the scope of Dorsomorphin's applications and highlights its capacity to bridge metabolic, immune, and regenerative research.

Conclusion and Future Outlook

Dorsomorphin (Compound C) stands as a pivotal tool for dissecting the intersection of metabolic, inflammatory, and differentiation pathways in contemporary biomedical research. Its capacity as an ATP-competitive AMPK inhibitor and BMP/Smad signaling modulator enables unique experimental designs—from probing immune cell function in obesity-related asthma to directing neural stem cell fate and modeling iron metabolism disorders. As research frontiers expand to encompass complex disease mechanisms, Dorsomorphin's versatility and mechanistic depth will continue to empower researchers in unlocking new therapeutic targets and advancing precision medicine. For researchers seeking reliability, depth, and flexibility, APExBIO's Dorsomorphin (Compound C) remains an indispensable reagent for next-generation discovery.